As of 2018, more than 3,200 Emerging Biopharma (EBP) companies (characterized by R&D spend of less than $200 million or prescription sales up to $500 million) have an active R&D drug pipeline. Of the 8,700 products or programs in active development, ranging...
Account-based marketing. It’s all the rage. Most B2B commercial teams are at least thinking of implementing account-based marketing (ABM) programs if they haven’t already. But why is it a must-have for life science sales and marketing teams? What exactly is ABM? Our...
Most of us welcomed 2020 with our sights set on new achievements, only to have our business activities and life as we know it significantly disrupted by a global pandemic. Disruptions to networking and business development activities, like canceled conferences,...
Amplion Lead Generation and Prospecting:A Guide for Life Science Sales and Marketing Teams FREE DOWNLOAD In this guide, you’ll learn ways to master: Want to upgrade your prospecting and lead gen processes for the better (and for good)? Establishing...
The COVID-19 pandemic has created so many difficult challenges for the world. Thankfully, the life science community has risen and continues to rise to meet some of the most pressing of these, bringing the collective brilliance and innovative thinking of diverse...
To our esteemed colleagues around the globe: The COVID-19 pandemic is going to get worse before it gets better, so the medical statistics demonstrate. At this point, it has already required us to adapt to social distancing and caused us all to reevaluate how we work...
Amplion’s Machine Learning Platform Accelerates Precision Medicine Collaboration Dx:Revenue™ solution rapidly identifies and qualifies drug and test developer partnership opportunities Effective partnerships between pharmaceutical companies, biotechs, academia,...
Seattle’s annual GeekWire Summit brings together thousands of tech and business leaders for a conversation about the future. This year, organizers are hosting a panel discussion on The Quest for Personalized Medicine that will include Dr. Amanda Enstrom, Amplion’s...
Biomarker Intelligence company to aggressively accelerate sales, marketing and execution of product roadmap Amplion, an Oregon-based Biomarker Intelligence company, announced the successful close of its Series A financing led by Greycroft with participation from...
Recent research on clinical trial success rates that caught our eye: We are especially encouraged to see a group from MIT carrying forward the torch of drug likelihood-of-approval (LOA) analysis. That group of researchers put together this great analysis of what they...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
